No more pediatric code blues on the floor: evolution of pediatric rapid response teams and situational awareness

Mary Sandquist1, Ken Tegtmeyer2

  • 1Division of Pediatric Critical Care Medicine, University of Louisville, Louisville, KY, USA.

Translational Pediatrics
|November 22, 2018
PubMed

Insights

Implementing pediatric rapid response teams can reduce in-hospital deaths. Early recognition of patient deterioration, using tools from parental intuition to big data, is key to preventing decline and improving outcomes.

Area of Science:

  • Pediatric critical care medicine
  • Hospital quality improvement
  • Patient safety

Background:

  • Code blues on inpatient, noncritical care units in children's hospitals are a significant challenge.
  • Effective interventions are needed to reduce mortality and improve patient outcomes.

Purpose of the Study:

  • To explore strategies for reducing or eliminating code blues in pediatric inpatient settings.
  • To highlight the role of rapid response teams and early patient deterioration recognition.

Main Methods:

  • Implementation of pediatric rapid response teams.
  • Utilizing various assessment methods for patient deterioration, from parental intuition to big data models.
  • Leveraging electronic medical records for predictive variable extraction.

Main Results:

  • Rapid response teams facilitate timely clinical interventions for deteriorating patients.
  • Early recognition systems can optimize patient monitoring and risk assessment.
  • Potential for reduced hospital-wide mortality and efficient transfers to the pediatric intensive care unit (PICU).

Conclusions:

  • Proactive identification of at-risk patients allows for timely interventions to prevent clinical decline.
  • Optimized resuscitation care in the PICU can improve outcomes when proactive measures are insufficient.
  • Effective pediatric rapid response systems are crucial for improving patient safety and outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
307
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
227
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
298
The Evidence for Evolution02:55

The Evidence for Evolution

Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K